Clicky

Amneal Pharmaceuticals, Inc.(AMRX) News

Date Title
Jul 29 Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
Jul 29 Wall Street Analysts Think Amneal (AMRX) Could Surge 43.82%: Read This Before Placing a Bet
Jul 29 Q1 Earnings Highs And Lows: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks
Jul 28 Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year?
Jul 28 2 Reasons to Avoid AMRX and 1 Stock to Buy Instead
Jul 21 Amneal Announces Proposed Refinancing of Existing Credit Agreement, including Private Offering of Senior Secured Notes Due 2032
Jul 21 Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results
Jul 18 Knight Therapeutics Announces Filing of New Drug Submission for CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Canada
Jul 12 Amneal Pharmaceuticals (AMRX) Announces FDA Approval of Prednisolone Acetate Ophthalmic Suspension
Jun 30 Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year?
Jun 26 5 Revealing Analyst Questions From Amneal’s Q1 Earnings Call
Jun 25 Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
Jun 12 Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension
Apr 17 Even though Amneal Pharmaceuticals (NASDAQ:AMRX) has lost US$78m market cap in last 7 days, shareholders are still up 125% over 5 years
Apr 11 Amneal Donates $1.5 Million to Support Patients During Parkinson’s Awareness Month
Apr 8 Amneal to Report First Quarter 2025 Results on May 2, 2025
Apr 7 Amneal Announces New Data from Phase 3 Study Showing Significant Improvements in Sleep Quality with CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Parkinson’s Disease
Jan 23 Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
Oct 1 Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases
Jul 29 Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags